Company Profile

Rhegen Bio

Rhegen Bio is a biotechnology company  with the world's leading mRNA technology. We are headquartered in Shenzhen and establish R&D as well as production centers in Shanghai and Wuhan. We have independently developed many platform technologies required for nucleic acid drugs such as mRNA design and synthesis platform and world's leading carrier free mRNA delivery systems. These technologies are used in the field of innovative drug R&D with huge market prospects and clinical value.

Rhegen Bio is devoted to developing mRNA-based vaccines and therapeutics, and we already have an intact technology platform as well as many unique innovative mRNA technologies with numbers of core patents. We can efficiently de novo design and develop highly accessible mRNA drugs responding to different clinical and pharmaceutical demands. We are committed to becoming the world's leading innovative biopharmaceutical company with core competitiveness.